How Institutional Funds Moved on GSK

Position changes disclosed in SEC Form 13F filings. These report a quarterly snapshot, not exact trade dates.

FundChangeQuarter
Point72 Asset Management, L.P. Point72 Asset Management, L.P. opened a new position worth $139,064,022. 2026-06-30
Caption Management, LLC Caption Management, LLC opened a new position worth $34,492,360. 2026-06-30
D. E. Shaw & Co., Inc. D. E. Shaw & Co., Inc. increased this position by 3227% ($1,606,029 -> $53,439,517). 2026-06-30
VAN ECK ASSOCIATES CORP VAN ECK ASSOCIATES CORP increased this position by 4571458% ($903 -> $41,281,169). 2026-06-30
Life Cycle Investment Partners Ltd Life Cycle Investment Partners Ltd opened a new position worth $27,786,794. 2026-06-30
RENAISSANCE TECHNOLOGIES LLC RENAISSANCE TECHNOLOGIES LLC exited a position previously worth $17,180,205. 2026-06-30
Qube Research & Technologies Ltd Qube Research & Technologies Ltd increased this position by 87% ($30,256,372 -> $56,548,966). 2026-06-30
Alyeska Investment Group, L.P. Alyeska Investment Group, L.P. exited a position previously worth $66,821,072. 2026-06-30

Which Funds Hold GSK

Largest reported positions as of 2026-06-30.

FundValueShares
Dodge & Cox $2,526,513,684 48,197,514
FMR LLC $1,347,885,152 25,713,185
PRIMECAP MANAGEMENT CO/CA/ $1,320,044,006 25,182,068
WELLINGTON MANAGEMENT GROUP LLP $590,933,071 11,273,046
Grantham, Mayo, Van Otterloo & Co. LLC $188,686,891 3,599,521
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC $178,939,549 3,413,574
Point72 Asset Management, L.P. $139,064,022 2,652,881
Connor, Clark & Lunn Investment Management Ltd. $127,417,609 2,430,706
DIMENSIONAL FUND ADVISORS LP $118,746,981 2,265,299
ENVESTNET ASSET MANAGEMENT INC $100,044,669 1,908,549

Data compiled from public SEC filings. This is informational reporting, not investment advice.

Soleus Capital Management, L.P.: 13F Portfolio Moves Tracked Quarterly

Chart-style summary of Soleus Capital Management, L.P.'s 13F portfolio changes for the quarter ending 2026-03-31, showing new positions, increases, and exits across healthcare and biotech stocks.

Soleus Capital Management, L.P. is a healthcare-focused institutional investor whose equity holdings are disclosed each quarter through SEC Form 13F filings. This profile tracks those disclosures over time, giving a running record of the fund’s reported buys, sells, and position size changes as new 13F data becomes available. Because 13F filings only capture a quarterly … Read more